LayerBio is developing a biodegradable nanoparticle drug delivery system for sustained release of an existing FDA-approved glaucoma drug.
It will be delivered through a simple office-based procedure and is expected to last a minimum of 4 to 6 months per dose. Other products being developed include a sustained-release product for cataract surgery and a novel wound dressing that releases growth factors to promote wound healing.
Medication Dispensing Intraocular Lens (mdIOL) for cataract surgery
This company is a spinout of the 2013 project, Medication Dispensing Intraocular Lens (mdIOL) for cataract surgery.